FASN and obesity due to melanocortin 4 receptor deficiency: MCL cell lines, in which FASN is highly and consistently expressed, exhibited significant apoptosis when treated with orlistat, an anti-obesity drug, which is also an inhibitor of FASN and is approved by the FDA [86] (Table 3).